Unicycive Therapeutics Inc
UNCY
Get informed when a big investor buys or sells
+ FollowMarket Cap$158.61M
Close$
$0.18
97.5% downside
Current Fair Value
97.5% downsideOvervalued by 97.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $158.61 Million |
|---|---|
| Enterprise Value | $122.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.67 |
| Beta | 1.77 |
| Outstanding Shares | 239,081,530 |
Return
| Return on Equity | -105.95% |
|---|---|
| Return on Assets | -62.03% |
| Return on Invested Capital | -93.64% |
Valuation & Multiples
| P/E Ratio | -44.17 |
|---|---|
| PEG | 1.88 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.44 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$11.11 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.57
Average shareholder expectationRevenue Estimate
$22.22 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.1848▲ 318.48% |
|---|---|
| Total Calls | 141,200▲ 143.03% |
| Total Puts | 449,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.24%▼ 38.85% |
|---|---|
| Total Invested | $65.21M▲ 38.67% |
| Investors Holding | 57▲ 20.00% |
ESG Score
No data